Specificity of HercepTest in Determining <i>HER-2</i>/<i>neu</i> Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System
Timothy W. Jacobs(Jacobs (United States)), Stuart J. Schnitt(Brigham and Women's Hospital)
Cited by 459
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Regulation of In Situ to Invasive Breast Carcinoma Transition
|Cancer Cell|2008|509